Physician profile
Ashley E Sbanotto
NPI 1588957120
$832.44
in general payments reported to CMS, 2019-2025
15 companies · $17.04 in 2025
The $17.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.95 · 2020: $18.00 · 2021: $52.31 · 2022: $358 · 2023: $274 · 2024: $44.46 · 2025: $17.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.36 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $251.96 | 2021-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Pfizer INC. | $173.29 | 2019-2023 | |
| Astellas Pharma US INC | $129.09 | 2022-2024 | Veozah |
| Minerva Surgical, INC | $49.29 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $32.27 | 2019-2021 | |
| Hologic Sales and Service, LLC | $27.39 | 2022-2024 | Acessa Provu System |
| Sumitomo Pharma America, INC. | $24.38 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $20.49 | 2021 | |
| Intuitive Surgical, INC. | $20.46 | 2023 | Da Vinci Surgical System |
| Shield Therapeutics INC | $20.15 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.04 | 2022 | |
| Novo Nordisk INC | $17.10 | 2023 | Wegovy |
| Ethicon US, LLC | $17.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.08 | 2022 | |
| Millicent US INC | $13.35 | 2023 | Femring |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Sbanotto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.